Table 4.
GBD Hearing Classification, dB HL | Sample No. | Depression, % | Mean PHQ-9 Score | OR (95% CI)a | |||
---|---|---|---|---|---|---|---|
Crude | Model 1 | Model 2 | Model 3 | ||||
All | |||||||
BE PTA <20 | 299 | 4.7 | 2.2 | 1 [Ref] | 1 [Ref] | 1 [Ref] | 1 [Ref] |
20 ≤ BE PTA < 35 | 614 | 3.9 | 2.2 | 0.9 (0.6–1.4) | 0.9 (0.6–1.5) | 0.9 (0.6–1.5) | 1.4 (0.6–2.9) |
35 ≤ BE PTA < 50 | 412 | 5.8 | 2.6 | 1.3 (0.8–2.4) | 1.5 (0.8–2.8) | 1.5 (0.8–2.8) | 2.1 (0.8–5.4) |
BE PTA ≥50 | 210 | 2.8 | 1.9 | 0.6 (0.2–1.5) | 0.8 (0.3–2.0) | 0.7 (0.3–1.8) | 1.1 (0.3–3.9) |
Men | |||||||
BE PTA <20 | 109 | 5.5 | 1.7 | 1 [Ref] | 1 [Ref] | 1 [Ref] | 1 [Ref] |
20 ≤ BE PTA < 35 | 295 | 4.0 | 1.8 | 1.0 (0.5–1.9) | 1.0 (0.5–2.0) | 1.1 (0.5–2.4) | 2.0 (0.5–8.1) |
35 ≤ BE PTA < 50 | 236 | 2.2 | 2.3 | 0.5 (0.2–1.1) | 0.5 (0.2–1.2) | 0.5 (0.2–1.2) | 0.5 (0.1–2.8) |
BE PTA ≥ 50 | 149 | 2.8 | 1.7 | 0.6 (0.2–1.8) | 0.7 (0.2–2.1) | 0.6 (0.2–1.8) | 1.0 (0.1–9.3) |
Women | |||||||
BE PTA <20 | 190 | 4.4 | 2.4 | 1 [Ref] | 1 [Ref] | 1 [Ref] | 1 [Ref] |
20 ≤ BE PTA < 35 | 319 | 3.8 | 2.5 | 0.8 (0.4–1.7) | 0.8 (0.4–1.7) | 0.8 (0.4–1.6) | 1.5 (0.6–3.5) |
35 ≤ BE PTA < 50 | 176 | 9.3 | 3.0 | 2.2 (1.1–4.2)b | 2.5 (1.2–5.1)b | 2.6 (1.3–5.3)b | 3.9 (1.3–11.3)b |
BE PTA ≥ 50 | 61 | 2.9 | 2.4 | 0.5 (0.1–3.0) | 0.8 (0.1–3.9) | 0.7 (0.1–3.6) | 0.9 (0.1–5.8) |
Abbreviations: BE, better ear; GBD, Global Burden of Disease; HL, hearing level; NHANES, National Health and Nutrition Examination Survey; OR, odds ratio; PHQ-9,9-item Patient Health Questionnaire; PTA, pure-tune average of thresholds at frequency 0.5, 1, 2, and 4 KHz; Ref, reference.
Model 1 was controlled for age, sex, and race/ethnicity; model 2 was controlled for age, sex, race/ethnicity, marriage, living alone, educational level, income, and health insurance; and model 3 was controlled for age, sex, race/ethnicity, marriage, living alone, educational level, income, health insurance, body mass index, smoking, binge drinking, self-reported health, cardiovascular disease, cancer, diabetes mellitus, hypertension, sleep disorder, hearing aids, tinnitus, and trouble seeing.
P <.05.